Unispeed Pharmaceuticals Private Limited

Unispeed Pharmaceuticals Private Limited - pharma in Baddi, Himachal Pradesh, India. FY 2026 financials & compliance.
CIN U24230HP2005PTC007610 Incorporated 24 June 2005 ROC Himachal Pradesh HQ Baddi, Himachal Pradesh, India
Active Private Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2025
₹74.03 Cr
▲ 8% YoY
Net profit · FY 2025
₹1.74 Cr
Net margin 2.3%
EBITDA · FY 2025
₹4.76 Cr
EBITDA margin 6.4%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹3.35 Cr
Issued & subscribed
Open charges
₹17.48 Cr
Satisfied ₹17.05 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
52
Provident fund records

About Unispeed Pharmaceuticals Private Limited

Data last updated:

Unispeed Pharmaceuticals Private Limited is a private limited company based in Baddi, Himachal Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 June 2005 and has been in existence for over 21 years.

The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24230HP2005PTC007610. Its GSTIN is 02AAACU7620B2ZZ (Himachal Pradesh). The company holds 3 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.35 Cr. It is led by directors including Satish Kumar and Manoj Kumar Sharma.

Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 445/2 Behind Wrigley’S Village Katha, Baddi, Himachal Pradesh, India – 173205.

As per the financials filed for FY 2025, the company reported a revenue of ₹74.03 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹1.74 Cr (net margin 2.3%) and EBITDA of ₹4.76 Cr (EBITDA margin 6.4%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 15% over five years.

The company has about 52 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹17.48 Cr and satisfied charges of ₹17.05 Cr on record. Court records list 17 cases involving the company, including 6 filed by the company and 11 filed against it; 10 cases are pending.

Unispeed Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0002311). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website usp.one.

Company details

CIN U24230HP2005PTC007610
Registration Number 007610
Incorporation Date 24 June 2005
ROC Himachal Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-CH-01-0002311

CIN history

Unispeed Pharmaceuticals has one previous CIN (Corporate Identification Number): U24230GJ2005PTC046325. The current CIN is U24230HP2005PTC007610, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24230HP2005PTC007610Current
U24230GJ2005PTC046325Previous
Key People
Satish Kumar Director Manoj Kumar Sharma Director Daman Singhal Director

Recognitions & Rankings of Unispeed Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Medium (2023-24)
Udyam number
UDYAM-CH-01-0002311

Contact details

Unispeed Pharmaceuticals Private Limited's registered office is in Baddi, Himachal Pradesh. Its website is usp.one. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    usp.one
  • Registered Address
    445/2 Behind Wrigley’S Village Katha, Baddi, Himachal Pradesh, India – 173205
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Unispeed Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Unispeed Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Unispeed Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Unispeed Pharmaceuticals Private Limited, buy the company report.

Financials of Unispeed Pharmaceuticals Private Limited

FY 2025 filings available

Unispeed Pharmaceuticals Private Limited reported revenue of ₹74.03 Cr (up 8% YoY) for FY 2025.

Revenue · FY 2025
₹74.03 Cr ▲ 8%
Net profit · FY 2025
₹1.74 Cr margin 2.3%
EBITDA · FY 2025
₹4.76 Cr margin 6.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 2%
5 years · compounded
▲ 15%
EBITDA CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 11%
5 years · compounded
▲ 15%

Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 8% growth in the latest year. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4.76 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.74 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin6.4%
Net Profit Margin2.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Unispeed Pharmaceuticals Private Limited, buy the company report.

Board of directors of Unispeed Pharmaceuticals Private Limited

Unispeed Pharmaceuticals has 4 current directors and 15 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Satish Kumar
Also directs: Rudraksha Entertainment LLP, SMD Chemi-Pharma Private Limited, Quadriga Biotech Private Limited and 4 more
Director20 Nov 20178 Years 11 MonthsCurrent
Manoj Kumar Sharma
Also directs: Orange Research Lab Limited
Director13 Jan 20242 Years 9 MonthsCurrent
Daman Singhal
Also directs: SMD Chemi-Pharma Private Limited
Director08 Dec 20178 Years 10 MonthsCurrent
Mayank SinghalDirector08 Dec 20178 Years 10 MonthsCurrent
View all directors

Peer comparison

Unispeed Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Biochemical and Synthetic Products Private Limited₹74.99 Cr (FY 2025)9.0%Hyderabad, Telangana, India
Farista Vanijya Private Limited₹74.9 Cr (FY 2024)25.0%Sonapur Hat, West Bengal, India
Atlas Pharmachem Industries Private Limited₹74.83 Cr (FY 2025)5.0%Ahmedabad, Gujarat, India
Casid Pharmaceuticals Private Limited₹74.41 Cr (FY 2025)28.0%Manachanalloor, Tamil Nadu, India
Sreepathi Pharmaceuticals Limited₹74.26 Cr (FY 2025)-17.0%Telangana, India
Unispeed Pharmaceuticals Private Limitedthis company₹74.03 Cr (FY 2025)₹1.74 Cr2.3%8.0%52Baddi, Himachal Pradesh, India
Spansules Pharmatech Private Limited₹73.76 Cr (FY 2025)-4.0%Hyderabad, Telangana, India
Shiva Biogenetic Laboratories Private Limited₹73.64 Cr (FY 2025)2.0%Baddi, Himachal Pradesh, India

To see the full peer comparison of Unispeed Pharmaceuticals Private Limited, buy the company report.

Auditor

Unispeed Pharmaceuticals Private Limited is audited by Shiv K Gupta & Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Shiv K Gupta & AssociatesFY 2023085397

Shareholding

The shareholding of Unispeed Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Unispeed Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹17.48 Cr
Satisfied charges
₹17.05 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹17.32 Cr
Others₹0.16 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
16 May 2025101098077Others₹16 LakhOpen
14 Dec 2021100519862Hdfc Bank Limited₹50 LakhOpen
15 Dec 2020100416463Hdfc Bank Limited₹16.82 CrOpen
07 Jul 2021100474315Hdfc Bank Limited₹20 LakhSatisfied
02 Jul 2020100353869Hdfc Bank Limited₹7.85 CrSatisfied

To see the full charge records of Unispeed Pharmaceuticals Private Limited, buy the company report.

Total charge records: 10 View all charges

MSME payment delays

Unispeed Pharmaceuticals Private Limited has 16 MSME Form 1 returns on record between 2019 and 2024, listing 4,264 overdue payments to 65 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 65)

SupplierAmount dueDue sinceReported on
Micropet Technology Private Limited
Jasco Paper Products
Printman
Tanuja Enterprises
an individual supplier

To see the full MSME payment records of Unispeed Pharmaceuticals Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Unispeed Pharmaceuticals Private Limited has a workforce of 52 employees on its EPFO records as of Aug 12, 2024, across 1 active EPFO establishment.

Employee count
52
Active EPFO establishments
1

GST

Unispeed Pharmaceuticals has 3 GST registrations: 1 active and 2 cancelled or inactive.

Total GSTINs
3
Active
1
Cancelled / inactive
2
GSTINStateStatusRegistered on
02AAACU7620B2ZZHimachal PradeshActive02 Jan 2018

To see the full GST registrations and return filing status of Unispeed Pharmaceuticals Private Limited, buy the company report.

Recent activity

Unispeed Pharmaceuticals Private Limited has 19 board changes on record since 2007: 4 appointments and 15 cessations. The latest: Manoj Kumar Sharma was appointed as Director on 13 Jan 2024.

AGM
Unispeed Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Charges
A charge registered on 07 Jul 2021 via Charge ID 100474315 with Hdfc Bank Limited was fully satisfied on 02 Jun 2025.
Charges
A charge with Others amounted to Rs. 0.16 Cr with Charge ID 101098077 was registered on 16 May 2025.
Filing
Unispeed Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Himachal Pradesh.
Charges
A charge with Hdfc Bank Limited of Rs. 16.82 Cr registered on 15 Dec 2020 with Charge ID 100416463 was modified on 15 Feb 2025.
Appointed
Manoj Kumar Sharma was appointed as Director.
Charges
A charge registered on 02 Jul 2020 via Charge ID 100353869 with Hdfc Bank Limited was fully satisfied on 04 Mar 2023.
Ceased
Sumatilal Kanhaiyalal Surana ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.50 Cr with Charge ID 100519862 was registered on 14 Dec 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.20 Cr with Charge ID 100474315 was registered on 07 Jul 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 16.82 Cr with Charge ID 100416463 was registered on 15 Dec 2020.
Ceased
Ajay Sharma ceased to be Additional Director.

29 earlier events are in the company report.

Frequently asked questions

Unispeed Pharmaceuticals is an active private limited company based in Baddi, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 June 2005 (21+ years old) and is registered under CIN U24230HP2005PTC007610.

Unispeed Pharmaceuticals has 4 current directors:

The latest financial statements of Unispeed Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Unispeed Pharmaceuticals is 02AAACU7620B2ZZ, registered in Himachal Pradesh. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.

The CIN (Corporate Identification Number) of Unispeed Pharmaceuticals is U24230HP2005PTC007610. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Unispeed Pharmaceuticals has 17 court cases on record: 6 filed by the company and 11 filed against it. 10 are pending. Most are in the high courts.

Unispeed Pharmaceuticals was incorporated on 24 June 2005, making it 21+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.

The peers of Unispeed Pharmaceuticals by revenue are Biochemical and Synthetic Products Private Limited, Farista Vanijya Private Limited, Atlas Pharmachem Industries Private Limited, Casid Pharmaceuticals Private Limited, Sreepathi Pharmaceuticals Limited and 2 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Manoj Kumar Sharma was appointed as Director on 13 Jan 2024. Sumatilal Kanhaiyalal Surana ceased to be Director on 18 Jan 2022. Ajay Sharma ceased to be Additional Director on 17 Nov 2020. Unispeed Pharmaceuticals has 19 board changes on record in total.

Yes, Unispeed Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-CH-01-0002311).

Unispeed Pharmaceuticals has 16 MSME Form 1 returns on record between 2019 and 2024, listing 4,264 overdue payments to 65 micro and small suppliers. The latest return was filed on 24 Apr 2024.

Unispeed Pharmaceuticals can be reached through the website usp.one. Its registered office is in Baddi, Himachal Pradesh, India.